申请人:Protagonist Therapeutics, Inc.
公开号:US20140193465A1
公开(公告)日:2014-07-10
The invention relates to disulfide-rich dimer molecules which inhibit binding of α4β7 to the mucosal addressin cell adhesion molecule (MAdCAM) in vivo, and show high selectivity against α4β1 binding.